David A. Siegel Pfizer Inc Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pfizer Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 9,330,500 shares of PFE stock, worth $245 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
9,330,500
Previous 16,952,600
44.96%
Holding current value
$245 Million
Previous $491 Million
49.54%
% of portfolio
0.6%
Previous 1.19%
Shares
30 transactions
Others Institutions Holding PFE
# of Institutions
3,354Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.64 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.09 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.68 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $148B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...